$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Detailed explanation of the functions and efficacy of Glasdegib
2026-02-01 22:25:32
Check Details
Is Acemini on Medicare? Interpretation of reimbursement conditions and latest policies
2026-02-01 22:25:32
Check Details
What reactions will occur after discontinuing ritexitinib? Discontinuation Risks and Precautions
2026-02-01 22:25:32
Check Details
When will sparsentan/sparsentan be available? Domestic and overseas listing time and approval progress tracking
2026-02-01 22:25:32
Check Details
What are the side effects of Ixazomib/Enleri? How to deal with it scientifically?
2026-02-01 22:25:32
Check Details
Is rubicatin/rubitidine available in China? How do Chinese patients obtain it?
2026-02-01 22:25:32
Check Details
Who is the manufacturer of Glasdegib?
2026-02-01 22:25:32
Check Details
How many times a day should you take pirfenidone/asri? Correct dosage and dosage adjustment guide
2026-02-01 22:25:32
Check Details
Are there generic versions of Canafenib? Domestic and foreign generic drug research and development and accessibility analysis
2026-02-01 22:25:32
Check Details
How much does the generic version of Sotolaxib cost? Comparison of market prices and effectiveness of generic drugs
2026-02-01 22:25:32
Check Details
How many boxes of adagrasib should be consumed in a month? Medication planning and economic burden analysis
2026-02-01 22:25:32
Check Details
Can I stop taking afatinib once I start taking it? What are the criteria for discontinuation of medication?
2026-02-01 22:25:32
Check Details
1
2
...
1362
1363
1364
1365
1366
1367
1368
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
IRX4 Transcription Factor: New Research Insights on Colorectal Cancer Treatment Targets
2
New Research Progress on Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Tumor Relationship
3
Tyrosine Kinase and JAK Inhibitors May Increase Keratinocyte Carcinoma Risk: New Research Reveals Drug Safety Findings
4
CLISGen Database: A New Tool for Cell Line Selection in Cancer Genetic Variation Research
5
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope
6
ARID1A Gene: A New Breakthrough in Tumor Immunotherapy, Turning "Cold Tumors" Hot
7
User Agreement
8
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
9
What is the most important information I should know about WELIREG?
10
How to take and store WELIREG
11
How to take TRUSELTIQ correctly
12
How to deal with LONSURF side effects (1)